Stock BOLD BOUNDLESS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Boundless Bio, Inc.

Equities

BOLD

US10170A1007

Market Closed - Nasdaq
Other stock markets
 03:58:33 2024-06-04 pm EDT 		5-day change 1st Jan Change
9.25 USD +1.87% Intraday chart for Boundless Bio, Inc. -3.65% 0.00%
Apr. 22 Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target MT
Apr. 22 Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. BOLD Stock
  4. Revisions Boundless Bio, Inc.